APOE and atherosclerosis: In a previous study, we identified a compound E1231 as a novel SIRT1 activator and demonstrated that it improved lipid and cholesterol metabolism in hyperlipidemic golden hamsters and an Apolipoprotein E knockout (ApoE−/−) mouse model of atherosclerosis [20].